Actively Recruiting
RSMI HEALS (Health Equity Advances Through Language Solutions) Study Comparing Remote Medical Interpreting Methods for Breast Cancer Patients with Limited English Proficiency
Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-05-12
700
Participants Needed
8
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating three different remote medical interpreting methods for breast cancer patients with limited English proficiency (LEP) who speak Spanish or Mandarin. The study focuses on patients with Stage II and III breast cancer and involves English-speaking healthcare providers who do not speak Spanish or Mandarin. The purpose is to compare these interpreting methods and understand their impact on communication errors and implementation potential. The study has two phases. Phase 1 is a randomized controlled trial comparing Remote Simultaneous Medical Interpreting (RSMI), Remote Consecutive Medical Interpreting (RCMI), and Remote Consecutive Video Medical Interpreting (RCVI) during outpatient clinical encounters. Phase 2 involves a mixed-methods evaluation to gather data on barriers, facilitators, and the potential for implementing these interpreting methods in clinical settings. Participants will be audio-recorded during their clinical encounters to assess the number of interpretation errors within 30 days. The study also collects feedback from clinic staff in Phase 2 to understand how well these interpreting methods can be integrated into practice. The trial is sponsored by Memorial Sloan Kettering Cancer Center and involves adult patients and healthcare providers over 18 years old. Participation includes appointments with oncology teams, audio recordings, and follow-up assessments.
CONDITIONS
Brief Title
A Study of Language Interpretation Solutions for People With Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Preferred language for healthcare is Spanish or Mandarin
- Limited English proficiency; cannot speak English "very well"
- Diagnosis of breast cancer or gastrointestinal cancer
- Visiting oncology teams for first or second appointment
- Agrees to be audio-recorded
- Providers must be breast or gastrointestinal cancer providers seeing patients
- Providers do not speak Spanish and/or Mandarin
- Providers agree to be audio-recorded
- Clinic staff worked at study sites during Phase 1 and agree to be audio-recorded (Phase 2 only)
You will not qualify if you...
- Significant psychiatric disturbance preventing consent or assessments
- Cognitive impairment (delirium or dementia) preventing consent or data collection
- No exclusion criteria for providers or Phase 2 clinic staff
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person or remote)
Duration - Up to 30 days
Participants receive one of three remote medical interpreting methods during their oncology appointments to assist communication between limited English proficient patients and English-speaking providers.
1 to 2 visits depending on appointment schedule
Duration - Concurrent with or following intervention period
Participants in the Remote Simultaneous Medical Interpreting group and clinic staff participate in audio-recorded evaluations to examine utilization, barriers, facilitators, and implementation potential of the intervention.
Additional assessments may occur depending on cohort assignment
Trial Site Locations
Total: 8 locations
1
Memorial Sloan Kettering Basking Ridge (Consent Only)
Basking Ridge, New Jersey, United States, 07920
Actively Recruiting
2
Memorial Sloan Kettering Monmouth (Consent Only)
Middletown, New Jersey, United States, 07748
Actively Recruiting
3
Memorial Sloan Kettering Bergen (Consent Only)
Montvale, New Jersey, United States, 07645
Actively Recruiting
4
Memorial Sloan Kettering Suffolk- Commack (Consent Only)
Commack, New York, United States, 11725
Actively Recruiting
5
Memorial Sloan Kettering Westchester (Consent Only)
Harrison, New York, United States, 10604
Actively Recruiting
6
Memorial Sloan Kettering at Ralph Lauren Center (All Protocol Activities)
New York, New York, United States, 10035
Actively Recruiting
7
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, United States, 10065
Actively Recruiting
8
Memorial Sloan Kettering Nassau (All Protocol Activities)
Rockville Centre, New York, United States, 11553
Actively Recruiting
Research Team
F
Francesca Gany, MD, MS
L
Lisa Diamond, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
4
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here